{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:55:45Z","timestamp":1781661345816,"version":"3.54.5"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtauto.2026.100363","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:30:18Z","timestamp":1771950618000},"page":"100363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intrathecal immunoglobulin production in the diagnosis, prognosis, and monitoring of autoimmune diseases of the central nervous system"],"prefix":"10.1016","volume":"12","author":[{"given":"Yves","family":"Renaudineau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Puissant-Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2026.100363_bib1","first-page":"263","article-title":"Inflammatory demyelinating diseases of the central nervous system","volume":"145","author":"Hoftberger","year":"2017","journal-title":"Handb. Clin. Neurol."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100363_bib2","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"Pruss","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100363_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"Meinl","year":"2006","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100363_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100363_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100363_bib8","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1093\/brain\/awad073","article-title":"The radiologically isolated syndrome: revised diagnostic criteria","volume":"146","author":"Lebrun-Frenay","year":"2023","journal-title":"Brain"},{"issue":"9 Suppl 2","key":"10.1016\/j.jtauto.2026.100363_bib9","first-page":"S38","article-title":"Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jtauto.2026.100363_bib10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 2","key":"10.1016\/j.jtauto.2026.100363_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10072-017-3034-2","article-title":"Cerebrospinal fluid analysis and the determination of oligoclonal bands","volume":"38","author":"Gastaldi","year":"2017","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100363_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103765","article-title":"Oligoclonal bands and kappa free light chains: competing parameters or complementary biomarkers?","volume":"24","author":"Konen","year":"2025","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100363_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11111444","article-title":"Cerebrospinal fluid IgM and oligoclonal IgG bands in multiple sclerosis: a meta-analysis of prevalence and prognosis","volume":"11","author":"Fonderico","year":"2021","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100363_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100363_bib15","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100363_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/pn-2023-003814","article-title":"Oligoclonal bands","volume":"24","author":"Willis","year":"2024","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104566","article-title":"Predictive factors of multiple sclerosis relapse after the first demyelinating event: a 5-year follow-up","volume":"71","author":"Kolcava","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100363_bib18","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1007\/s00415-024-12304-5","article-title":"Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score","volume":"271","author":"Mallucci","year":"2024","journal-title":"J. Neurol."},{"issue":"Pt 7","key":"10.1016\/j.jtauto.2026.100363_bib19","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","volume":"138","author":"Tintore","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71315-4","article-title":"The presence of oligoclonal bands predicts conversion to multiple sclerosis in isolated myelitis","volume":"14","author":"Monschein","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2026.100363_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2020-325274","article-title":"Early factors associated with later conversion to multiple sclerosis in patients presenting with isolated myelitis","author":"Murphy","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.jtauto.2026.100363_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28271","article-title":"Risk factors and time to clinical symptoms of multiple sclerosis among patients with radiologically isolated syndrome","volume":"4","author":"Lebrun-Frenay","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100363_bib23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/awy021","article-title":"Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome","volume":"141","author":"Matute-Blanch","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100363_bib24","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00415-021-10791-4","article-title":"Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEM","volume":"269","author":"Rojas","year":"2022","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100363_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jamaneurol.2025.1481","article-title":"Prognostic factors for multiple sclerosis symptoms in radiologically isolated syndrome","volume":"82","author":"Fissolo","year":"2025","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100363_bib26","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000395","article-title":"Radiologically isolated syndrome in children: clinical and radiologic outcomes","volume":"4","author":"Makhani","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jtauto.2026.100363_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104948","article-title":"A multicenter study of radiologically isolated syndrome in children and adolescents: can we predict the course?","volume":"79","author":"Yilmaz","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100363_bib28","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1474-4422(25)00304-7","article-title":"2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis","volume":"24","author":"Barkhof","year":"2025","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100363_bib29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1468-1331.2007.01859.x","article-title":"Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis","volume":"14","author":"Koch","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100363_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/1352458512459684","article-title":"Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression","volume":"19","author":"Lourenco","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2026.100363_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103220","article-title":"Reinforcing the evidence of oligoclonal bands as a prognostic factor in patients with multiple sclerosis","volume":"56","author":"Ben Noon","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100363_bib32","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/jnnp-2023-333307","article-title":"Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study","volume":"95","author":"Dekeyser","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12974-017-0812-y","article-title":"Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study","volume":"14","author":"Farina","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94423-x","article-title":"Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study","volume":"11","author":"Karrenbauer","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97543-6","article-title":"Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study","volume":"11","author":"McKay","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2026.100363_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105391","article-title":"The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis","volume":"83","author":"Taskiran","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6-7","key":"10.1016\/j.jtauto.2026.100363_bib37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.20344\/amp.22380","article-title":"Multiple sclerosis disease-modifying treatment algorithms: 2025 positioning of the Portuguese multiple sclerosis study group","volume":"38","author":"Capela","year":"2025","journal-title":"Acta Med. Port."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.163.1.41","article-title":"Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis","volume":"163","author":"Walsh","year":"1986","journal-title":"J. Exp. Med."},{"issue":"1-2","key":"10.1016\/j.jtauto.2026.100363_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2013.09.003","article-title":"The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis","volume":"264","author":"Axelsson","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100363_bib40","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s10072-024-07930-w","article-title":"Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of patients with multiple sclerosis: a systematic review and meta-analysis","volume":"46","author":"Liampas","year":"2025","journal-title":"Neurol. Sci."},{"issue":"14","key":"10.1016\/j.jtauto.2026.100363_bib41","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1177\/1352458514538111","article-title":"Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study","volume":"20","author":"Mancuso","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2026.100363_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.msard.2018.10.006","article-title":"Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study","volume":"27","author":"Rejdak","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100363_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11122230","article-title":"Natalizumab induces changes of cerebrospinal fluid measures in multiple sclerosis","volume":"11","author":"Ganapathy Subramanian","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jtauto.2026.100363_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103931","article-title":"Immunological consequences of cladribine treatment in multiple sclerosis: a real-world study","volume":"64","author":"Rolfes","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jtauto.2026.100363_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231211077","article-title":"Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response","volume":"16","author":"Teschner","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-020-01824-2","article-title":"Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: results from 163 lumbar punctures in 100 adult patients","volume":"17","author":"Jarius","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100363_bib47","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the neuromyelitis optica study group (NEMOS). Part I: diagnosis and differential diagnosis","volume":"270","author":"Jarius","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.msard.2017.08.005","article-title":"Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: a multicenter cohort study","volume":"17","author":"Kessler","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"Pt 11","key":"10.1016\/j.jtauto.2026.100363_bib49","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100363_bib50","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1007\/s00415-024-12382-5","article-title":"Correlation between severe attacks and serum aquaporin-4 antibody titer in neuromyelitis optica spectrum disorder","volume":"271","author":"Wang","year":"2024","journal-title":"J. Neurol."},{"issue":"1-2","key":"10.1016\/j.jtauto.2026.100363_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jtauto.2026.100363_bib52","article-title":"Comparison of the clinical and laboratory characteristics of neuromyelitis optica spectrum disorder with or without cerebrospinal fluid oligoclonal bands: a cohort with 36-month follow-up","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100363_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101413","article-title":"Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia","volume":"36","author":"Drulovic","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jtauto.2026.100363_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104730","article-title":"Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients","volume":"75","author":"Lana-Peixoto","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100363_bib55","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.26858","article-title":"Time to disability milestones and annualized relapse rates in NMOSD and MOGAD","volume":"95","author":"Duchow","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.msard.2018.12.011","article-title":"Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis\/preventive treatment, MRI lesion length and presence of symptomatic brain lesions","volume":"28","author":"Mealy","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jtauto.2026.100363_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105935","article-title":"Blood neutrophils, oligoclonal bands and bridging corticosteroids as predictive factors for MOGAD course: insights from a multicentric Portuguese cohort","volume":"92","author":"Neves","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100363_bib58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/13524585241311435","article-title":"Evaluation of the predictive value of CSF-restricted oligoclonal bands on residual disability and risk of relapse in adult patients with MOGAD: MOGADOC study","volume":"31","author":"Ramdani","year":"2025","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2026.100363_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1211776","article-title":"Comparing clinical and imaging features of patients with MOG antibody-positivity and with and without oligoclonal bands","volume":"14","author":"Tomizawa","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100363_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105034","article-title":"Dual positivity for anti-MOG and oligoclonal bands: unveiling unique clinical profiles and implications","volume":"79","author":"Ganelin-Cohen","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jtauto.2026.100363_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105672","article-title":"Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","volume":"87","author":"Rempe","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13054-024-05233-2","article-title":"Clinical features and factors associated with outcomes of antibody-negative autoimmune encephalitis in patients requiring intensive care","volume":"29","author":"Li","year":"2025","journal-title":"Crit. Care"},{"issue":"12","key":"10.1016\/j.jtauto.2026.100363_bib63","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1007\/s00415-024-12680-y","article-title":"Long-term outcomes in antibody-negative autoimmune encephalitis: a retrospective study","volume":"271","author":"Mangioris","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib64","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3389\/fneur.2019.00804","article-title":"Cerebrospinal fluid findings in patients with autoimmune Encephalitis-A systematic analysis","volume":"10","author":"Blinder","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib65","article-title":"Comparing clinical features, severity and prognosis of autoimmune encephalitis and with and without oligoclonal bands","volume":"14","author":"Xue","year":"2023","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100363_bib66","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001086","article-title":"CSF findings in acute NMDAR and LGI1 antibody-associated autoimmune encephalitis","volume":"8","author":"Durr","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jtauto.2026.100363_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.646940","article-title":"Longitudinal CSF findings in autoimmune Encephalitis-A monocentric cohort study","volume":"12","author":"Zrzavy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100363_bib68","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.2147\/JIR.S504003","article-title":"Abnormal CSF-specific OCBs in neuronal surface antibody-associated autoimmune encephalitis differentiating from viral encephalitis","volume":"18","author":"Qiao","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.jtauto.2026.100363_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1405337","article-title":"Cognitive impairments in autoimmune encephalitis: the role of autoimmune antibodies and oligoclonal bands","volume":"15","author":"Rozenberg","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100363_bib70","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2147\/JIR.S383161","article-title":"CSF findings in Chinese patients with NMDAR, LGI1 and GABABR antibody-associated encephalitis","volume":"17","author":"Qiao","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100363_bib71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00415-025-13069-1","article-title":"Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study","volume":"272","author":"Seery","year":"2025","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.jtauto.2026.100363_bib72","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/acn3.70118","article-title":"Glial fibrillary acidic protein astrocytopathy based on a two-center Chinese cohort study","volume":"12","author":"Wu","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109066","article-title":"Kappa-index: real-life evaluation of a new tool for multiple sclerosis diagnosis","volume":"241","author":"Marlas","year":"2022","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib74","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/13524585221134217","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a consensus statement","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2026.100363_bib75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cca.2020.04.029","article-title":"Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusing","volume":"507","author":"Susse","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100363_bib76","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1212\/01.WNL.0000055864.08740.CB","article-title":"The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study","volume":"60","author":"Davies","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jtauto.2026.100363_bib77","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1093\/brain\/awac220","article-title":"The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria","volume":"145","author":"Arrambide","year":"2022","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/13524585221134213","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult. Scler."},{"issue":"11-12","key":"10.1016\/j.jtauto.2026.100363_bib79","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1177\/13524585241274034","article-title":"The kappa free light chains index is an accurate diagnostic biomarker for paediatric multiple sclerosis","volume":"30","author":"Sarthou","year":"2024","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100363_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70411","article-title":"Optimized Kappa-index test protocol to detect intrathecal immunoglobulin synthesis in multiple sclerosis","volume":"32","author":"Bjorklund","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100363_bib81","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001005","article-title":"Kappa-free light chains in CSF predict early multiple sclerosis disease activity","volume":"8","author":"Berek","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.jtauto.2026.100363_bib82","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200156","article-title":"Kappa free light chain index predicts disease course in clinically and radiologically isolated syndromes","volume":"10","author":"Levraut","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jtauto.2026.100363_bib83","article-title":"Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis","volume":"1","author":"Menendez-Valladares","year":"2015","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77029-7","article-title":"Intrathecal kappa free light chains as markers for multiple sclerosis","volume":"10","author":"Vecchio","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100363_bib85","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214433","article-title":"Association of CSF Kappa-free light chains with cortical and periventricular brain damage in multiple sclerosis","volume":"105","author":"Damulina","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2026.100363_bib86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.msard.2019.02.001","article-title":"Kappa free light chains could predict early disease course in multiple sclerosis","volume":"30","author":"Vecchio","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100363_bib87","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/13524585251344807","article-title":"Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosis","volume":"31","author":"Berek","year":"2025","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100363_bib88","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1007\/s00415-023-11817-9","article-title":"Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosis","volume":"270","author":"Rosenstein","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105734","article-title":"Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients","volume":"88","author":"Tortosa-Carreres","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089945","article-title":"Kappa free light chains: diagnostic and prognostic relevance in MS and CIS","volume":"9","author":"Presslauer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2026.100363_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1223514","article-title":"Kappa free light chains index in multiple sclerosis very long-term prognosis","volume":"14","author":"Arroyo-Pereiro","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100363_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1658182","article-title":"Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis","volume":"16","author":"Schmidauer","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100363_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12030720","article-title":"Decreased intrathecal concentrations of free light chains Kappa in multiple sclerosis patients taking very high effective disease-modifying treatment","volume":"12","author":"Susse","year":"2022","journal-title":"Diagnostics"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100363_bib94","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70291","article-title":"Kappa free light chain index correlates with prognostic biomarkers in multiple sclerosis and decreases slowly following treatment","volume":"32","author":"Duell","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.jtauto.2026.100363_bib95","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/ene.15897","article-title":"Relevance of kappa free light chains index in patients with aquaporin-4 or myelin-oligodendrocyte-glycoprotein antibodies","volume":"30","author":"Deschamps","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100363_bib96","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000892","article-title":"Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy","volume":"7","author":"Susse","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1016\/j.jtauto.2026.100363_bib97","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200386","article-title":"Diagnostic utility of Kappa free light chain index in adults with inaugural optic neuritis","volume":"12","author":"Demortiere","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jtauto.2026.100363_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577122","article-title":"Kappa free light chains index in the differential diagnosis of multiple sclerosis from neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders","volume":"339","author":"Cavalla","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100363_bib99","first-page":"1175","article-title":"KFLC-index distinguishes multiple sclerosis from anti-myelin oligodendrocyte glycoprotein and aquaporin 4 diseases in a Chinese cohort","volume":"96","author":"Tan","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.25648","article-title":"Comparison of the response to rituximab between myelin oligodendrocyte glycoprotein and Aquaporin-4 antibody diseases","volume":"87","author":"Durozard","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102251","article-title":"Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients","volume":"44","author":"Whittam","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jtauto.2026.100363_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123146","article-title":"Kappa index in the diagnostic work-up of autoimmune encephalitis","volume":"463","author":"De Napoli","year":"2024","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44427-6","article-title":"The role of intrathecal free light chains kappa for the detection of autoimmune encephalitis in subacute onset neuropsychiatric syndromes","volume":"13","author":"Bertram","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jtauto.2026.100363_bib104","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/acn3.70103","article-title":"Relevance of Kappa and Lambda free light chains in autoimmune astrocytopathy associated with Anti-GFAP antibodies","volume":"12","author":"Levraut","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5507\/bp.2008.038","article-title":"Correlation of the IgG index and oligoclonal bands in the cerebrospinal fluid of patients with multiple sclerosis","volume":"152","author":"Mares","year":"2008","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.jtauto.2026.100363_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.675307","article-title":"Cerebrospinal fluid findings in 541 patients with clinically isolated syndrome and multiple sclerosis: a monocentric study","volume":"12","author":"Berek","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100363_bib107","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3389\/fimmu.2020.01799","article-title":"IgG index revisited: diagnostic utility and prognostic value in multiple sclerosis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100363_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102382","article-title":"Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis","volume":"45","author":"Akaishi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100363_bib109","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001030","article-title":"Effects of natalizumab therapy on intrathecal immunoglobulin G production indicate targeting of plasmablasts","volume":"8","author":"Schluter","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13613-025-01475-7","article-title":"Predicting intrathecal immunoglobulin synthesis in the ICU: a comparative study of IgG-based indexes","volume":"15","author":"Balcerac","year":"2025","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.jtauto.2026.100363_bib111","article-title":"A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106828","article-title":"Clinical value of plasma C1q, C3, and C4 in NMOSD and MOGAD","volume":"104","author":"Wu","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib113","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acn3.52273","article-title":"Autoimmune brainstem encephalitis: clinical associations, outcomes, and proposed diagnostic criteria","volume":"12","author":"Gilligan","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100363_bib114","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.2169\/internalmedicine.4625-24","article-title":"Markedly elevated IgG index: a key to differentiating neurosyphilis from autoimmune limbic encephalitis","volume":"64","author":"Sanpei","year":"2025","journal-title":"Intern. Med."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100363_bib115","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp-2024-333554","article-title":"Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis","volume":"95","author":"Greco","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib116","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001095","article-title":"Myelin oligodendrocyte glycoprotein-immunoglobulin G in the CSF: clinical implication of testing and association with disability","volume":"9","author":"Kwon","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"10.1016\/j.jtauto.2026.100363_bib117","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1093\/brain\/awad122","article-title":"Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids","volume":"146","author":"Matsumoto","year":"2023","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.jtauto.2026.100363_bib118","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1177\/1352458518811597","article-title":"Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis","volume":"25","author":"Oliveira","year":"2019","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100363_bib119","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200035","article-title":"Temporal dynamics of MOG antibodies in children with acquired demyelinating syndrome","volume":"9","author":"Wendel","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100363_bib120","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neurol.2025.04.012","article-title":"French guidelines for the diagnosis and management of MOG antibody-associated disease","volume":"181","author":"Giorgi","year":"2025","journal-title":"Rev. Neurol. (Paris)"},{"issue":"14","key":"10.1016\/j.jtauto.2026.100363_bib121","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":"Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jtauto.2026.100363_bib122","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s13760-025-02853-5","article-title":"Influencing factors and clinical value of anti-aquaporin-4 antibody in cerebrospinal fluid: a study of 82 patients with neuromyelitis optica spectrum disorder","volume":"125","author":"Peng","year":"2025","journal-title":"Acta Neurol. Belg."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100363_bib123","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jnnp-2024-334090","article-title":"Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: a multicentre study","volume":"96","author":"Siriratnam","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jtauto.2026.100363_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.746959","article-title":"Serum aquaporin 4-Immunoglobulin G titer and neuromyelitis optica spectrum disorder activity and severity: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100363_bib125","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ana.26722","article-title":"Alterations in Aquaporin-4-IgG serostatus in 986 patients: a laboratory-based longitudinal analysis","volume":"94","author":"Majed","year":"2023","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100363_bib127","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200318","article-title":"Autoimmune encephalitis and paraneoplastic neurologic syndromes: a nationwide study on epidemiology and antibody testing performance","volume":"11","author":"Kerstens","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100363_bib128","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200108","article-title":"Prognostic value of persistent CSF antibodies at 12 months in Anti-NMDAR encephalitis","volume":"10","author":"Ciano-Petersen","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jtauto.2026.100363_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106550","article-title":"The practical uses of serum neurofilament light chain as a biomarker in multiple sclerosis","volume":"100","author":"Coker","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100363_bib130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00415-025-13093-1","article-title":"The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review","volume":"272","author":"Freedman","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2025.100550","article-title":"The role of neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: advancing clinical applications","volume":"38","author":"Samadzadeh","year":"2025","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.jtauto.2026.100363_bib132","article-title":"Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study","volume":"16","author":"Wiendl","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100363_bib133","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100363_bib134","article-title":"The role of glial fibrillary acidic protein as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis","volume":"60","author":"Shaygannejad","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12865-025-00735-2","article-title":"Clinical applications and diagnostic research of GFAP and NfL in MS and NMOSD: a meta-analysis","volume":"26","author":"Lin","year":"2025","journal-title":"BMC Immunol."},{"key":"10.1016\/j.jtauto.2026.100363_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.jtauto.2026.100363_bib137","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jnnp-2025-335831","article-title":"Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis","volume":"96","author":"Abdelhak","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jtauto.2026.100363_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.647618","article-title":"Serum neurofilament light and GFAP are associated with disease severity in inflammatory disorders with Aquaporin-4 or myelin oligodendrocyte glycoprotein antibodies","volume":"12","author":"Chang","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jtauto.2026.100363_bib139","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2022-330412","article-title":"Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder","volume":"94","author":"Aktas","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib140","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jamaneurol.2024.4400","article-title":"Blood-based biomarkers for identifying disease activity in AQP4-IgG-Positive neuromyelitis optica spectrum disorder","volume":"82","author":"Kim","year":"2025","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib141","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12974-021-02138-7","article-title":"Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder","volume":"18","author":"Schindler","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.jtauto.2026.100363_bib142","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/jnnp-2024-335137","article-title":"Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study","volume":"96","author":"Marignier","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib143","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200347","article-title":"Neurofilament light chain as a discriminator of disease activity status in MOG antibody-associated disease","volume":"12","author":"Gomes","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"10.1016\/j.jtauto.2026.100363_bib144","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70207","article-title":"Glial fibrillary acid protein reflects disease activity in autoimmune encephalitis","volume":"32","author":"Piepgras","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"21","key":"10.1016\/j.jtauto.2026.100363_bib145","doi-asserted-by":"crossref","first-page":"e2204","DOI":"10.1212\/WNL.0000000000207221","article-title":"Predictive value of serum neurofilament light chain levels in Anti-NMDA receptor encephalitis","volume":"100","author":"Brenner","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib146","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200346","article-title":"Long-term clinical and biological prognostic factors of Anti-NMDA receptor encephalitis in children","volume":"12","author":"Mazowiecki","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jtauto.2026.100363_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.719432","article-title":"CSF-neurofilament light chain levels in NMDAR and LGI1 encephalitis: a national cohort study","volume":"12","author":"Nissen","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100363_bib148","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200370","article-title":"Contribution of blood biomarkers to multiple sclerosis diagnosis","volume":"12","author":"Comabella","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"14","key":"10.1016\/j.jtauto.2026.100363_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146898","article-title":"Combining CSF and serum biomarkers to differentiate mechanisms of disability worsening in multiple sclerosis","volume":"26","author":"Monreal","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2026.100363_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1477335","article-title":"Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels","volume":"15","author":"Quintanilla-Bordas","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jtauto.2026.100363_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104573","article-title":"Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study","volume":"91","author":"Hegen","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jtauto.2026.100363_bib152","article-title":"Fluid biomarkers in multiple sclerosis: from current to future applications","volume":"44","author":"Di Filippo","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100363_bib153","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12883-022-02752-9","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: characteristics and rapid diagnostic approach in the emergency department","volume":"22","author":"Xu","year":"2022","journal-title":"BMC Neurol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902600016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902600016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:22:44Z","timestamp":1781659364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258990902600016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":153,"alternative-id":["S258990902600016X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100363","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal immunoglobulin production in the diagnosis, prognosis, and monitoring of autoimmune diseases of the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100363"}}